KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $32.6 million.

  • Dynavax Technologies' Free Cash Flow rose 7985.76% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.5 million, marking a year-over-year increase of 25525.81%. This contributed to the annual value of $60.2 million for FY2024, which is 3763.15% down from last year.
  • Dynavax Technologies' Free Cash Flow amounted to $32.6 million in Q3 2025, which was up 7985.76% from $22.0 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Free Cash Flow high stood at $117.5 million for Q4 2021, and its period low was -$52.4 million during Q1 2022.
  • Over the past 5 years, Dynavax Technologies' median Free Cash Flow value was $27.3 million (recorded in 2023), while the average stood at $30.0 million.
  • As far as peak fluctuations go, Dynavax Technologies' Free Cash Flow soared by 81136.75% in 2021, and later plummeted by 24455.01% in 2022.
  • Over the past 5 years, Dynavax Technologies' Free Cash Flow (Quarter) stood at $117.5 million in 2021, then crashed by 71.6% to $33.4 million in 2022, then crashed by 63.9% to $12.0 million in 2023, then surged by 311.3% to $49.5 million in 2024, then crashed by 34.2% to $32.6 million in 2025.
  • Its Free Cash Flow was $32.6 million in Q3 2025, compared to $22.0 million in Q2 2025 and -$23.6 million in Q1 2025.